News and Insights of 3D Printing and Manufacturing
Walmart has partnered with SmileDirectClub, a Nashville-based teledentistry company that uses 3D printing to make aligners, to exclusively offer its line of oral care products.
3D printed patient-specific airway stents, developed by a doctor at Cleveland Clinic, a nonprofit multispecialty academic medical center in Ohio, has received clearance from the U.S. Food and Drug Administration (FDA).
A worldwide collective of researchers and scientists from universities, institutions, and hospitals have come together to produce a roadmap for 3D bioprinting.
Researchers from the University of Toronto (UoT) and Sunnybrook Health Sciences Centre have developed a handheld device capable of 3D bioprinting sheets of skin that can heal burn wounds.
A payload containing 3D printed supplies for the 3D BioFabrication Facility (BFF) has arrived on board the International Space Station (ISS) docked 248 miles above the Earth’s surface. The cargo contained samples of human cells, bio-inks, and a set of new 3D printed ceramic fluid manifolds to replace the previously used printed polymers.
A 3D printed tumour designed and fabricated by 3D LifePrints, a UK-based medical technology company, has aided surgeons in the removal of a cancerous mass in six-year-old, Leah Bennett.
UPM, a Finnish alternative energy and material company, has launched a range of bioinks known as GrowInk, designed for various 3D bioprinting applications such as tissue engineering and regenerative medicine.
Researchers at the Wake Forest Institute for Regenerative Medicine (WFIRM) in North Carolina have 3D bioprinted a microscopic model of the human body containing most of the vital organs. The miniature system will be used to detect potentially harmful effects of drugs before they are trialed with humans.
Merck, the global pharmaceutical company, has announced plans to work with AMCM, an EOS Group company that builds custom additive manufacturing machines. The two companies will work on developing and producing 3D printed tablets, first for clinical trials, then later for commercial manufacturing.
UK-based engineering technologies company, Renishaw, has announced a milestone in a medical study seeking to help sufferers with progressive nervous system disorder Parkinson disease. The study looks at a patented intraparenchymal drug delivery device and is the completion of a joint Phase 1-2 clinical study with pharmaceuticals expert Herantis Pharma.